Pretreatment With BTK Inhibitors Improved the Sensitivity of DLBCL Cells to CAR-T Cells in a Coculture System by Downregulating the Polarisation of M2 Macrophages. [PDF]
J Cell Mol MedQi Y +6 more
europepmc +1 more source
Effects of Inhibitors against Syk-BTK-PI3K Signaling on Platelet Function [PDF]
Tyrosine kinases mediate response of blood cells to stimuli and small molecule tyrosine kinase inhibitors (TKIs) serve important roles as drugs in managing hematological diseases.
Lofurno, Elizabeth R.
core
Cutaneous Adverse Effects in Patients Treated with BTK Inhibitors. [PDF]
Cancers (Basel)Robak E, Robak T.
europepmc +1 more source
Efficacy and safety of BTK inhibitors in Richter's transformation: a systematic review of clinical evidence. [PDF]
Front OncolDirican CD +7 more
europepmc +1 more source
Letter to the Editor: Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells. [PDF]
Int J Biol SciLiu M, Zhao Z.
europepmc +1 more source
Infectious adverse events associated with novel Bruton tyrosine kinase (BTK) inhibitors in adults with chronic lymphocytic leukaemia: A meta-analysis of randomized controlled trials. [PDF]
Br J HaematolJanc JJ +3 more
europepmc +1 more source
Clinical Safety Profile of Bruton's Tyrosine Kinase (BTK) Inhibitors in Chronic Lymphocytic Leukaemia: A Real-World Ambispective Study From India. [PDF]
CureusPradhan A, Panchal HP.
europepmc +1 more source
Cardiac safety profiles of first-generation vs second-generation BTK inhibitors: a meta-analysis. [PDF]
OncologistMushtaq A +10 more
europepmc +1 more source
Transition Into Clinical Routine and Survival Outcomes of BCL2- and BTK Inhibitors: An Analysis of Patient Data From the GCLLSG Registry. [PDF]
Eur J HaematolKutsch N +16 more
europepmc +1 more source
Systemic high-dose MTX and BTK inhibitors in vitreoretinal lymphoma: efficacy and survival analysis. [PDF]
Blood SciGao J +8 more
europepmc +1 more source